New England Research & Management’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
Other funds holding INCY
BBA
New England Research & Management's INCY Position: Q2 2026 in Review
New England Research & Management reduced its Incyte (INCY) stake by 78% in Q2 2026, selling an estimated $1.27M and leaving 3,575 shares worth $405K. The position accounts for 0.16% of the portfolio, ranked #110.
New England Research & Management first reported a position in INCY in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.72M in Q4 2025. 855 funds tracked by Wall St. Rank hold INCY as of Q2 2026.
- New England Research & Management held 3,575 shares of Incyte worth $405K as of Q2 2026.
- New England Research & Management sold 12,775 Incyte shares in Q2 2026, an estimated $1.27M.
- Incyte made up 0.16% of New England Research & Management's portfolio in Q2 2026, its #110 holding.
- New England Research & Management first reported a position in Incyte in Q4 2025 and has held it in 3 quarters since.
- New England Research & Management's Incyte position peaked at $1.72M in Q4 2025.
- 855 funds tracked by Wall St. Rank held Incyte as of Q2 2026.
Based on New England Research & Management's 13F filing for Q2 2026, filed 9 Jul 2026.